Production (Stage)
Proto Script Pharmaceutical Corp.
PSCR
$0.0003
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | ||||
|---|---|---|---|---|---|
| Revenue | 120.28% | -17.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 120.28% | -17.28% | |||
| Cost of Revenue | -54.69% | 172.82% | |||
| Gross Profit | 610.30% | -71.95% | |||
| SG&A Expenses | 9.08% | -25.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.91% | -10.35% | |||
| Operating Income | 64.99% | 6.69% | |||
| Income Before Tax | 14.70% | 34.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.70% | 34.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.70% | 34.26% | |||
| EBIT | 64.99% | 6.69% | |||
| EBITDA | 65.74% | 6.82% | |||
| EPS Basic | 14.71% | -100.00% | |||
| Normalized Basic EPS | 14.29% | -100.00% | |||
| EPS Diluted | 14.71% | -100.00% | |||
| Normalized Diluted EPS | 14.29% | -100.00% | |||
| Average Basic Shares Outstanding | 0.00% | -67.40% | |||
| Average Diluted Shares Outstanding | 0.00% | -67.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||